pbpk model code (MathWorks Inc)
90
Structured Review
MathWorks Inc
pbpk model code
Pbpk Model Code, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbpk+model+code/pm39494970-346-14-19
Average 90 stars, based on 1 article reviews
Pbpk Model Code, supplied by MathWorks Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pbpk+model+code/pm39494970-346-14-19
Average 90 stars, based on 1 article reviews
pbpk model code - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Personalized metronomic radiopharmaceutical therapy through injection profile optimization via physiologically based pharmacokinetic (PBPK) modeling Article Snippet: A PBPK model, consisting of twenty-one Article Title: Quantification and prediction of human fetal (-)-Δ 9 -tetrahydrocannabinol/(±)-11-OH-Δ 9 -tetrahydrocannabinol exposure during pregnancy to inform fetal cannabis toxicity Article Snippet: However, the reviewer is correct in that the fetal part of the Article Title: A minimal PBPK model to accelerate preclinical development of drugs against tuberculosis Article Snippet: The model was benchmarked in terms of computational time with a reference full-body PBPK model available in Article Title: Making PBPK models more reproducible in practice Article Snippet: We have created an original Article Title: Making PBPK models more reproducible in practice. Article Snippet: Writing an original, reproducible, and reusable Article Title: Making PBPK models more reproducible in practice. Article Snippet: • We illustrate our recommendations by creating and publishing an example of reproducible and Concentration Assay:Article Title: Determining tissue distribution of the oral antileishmanial agent miltefosine: a physiologically-based pharmacokinetic modeling approach. Article Snippet: Miltefosine (MTS) is the only approved oral drug for treating leishmaniasis caused by intracellular Leishmania parasites that localize in macrophages of the liver, spleen, skin, bone marrow, and lymph nodes.. MTS is extensively distributed in tissues and has prolonged elimination half-lives due to its high plasma protein binding, slow metabolic clearance, and minimal urinary excretion.. Thus, understanding and predicting the tissue distribution of MTS help assess therapeutic and toxicologic outcomes of MTS, especially in special populations, e.g., pediatrics. Clinical Proteomics:Article Title: Determining tissue distribution of the oral antileishmanial agent miltefosine: a physiologically-based pharmacokinetic modeling approach. Article Snippet: Miltefosine (MTS) is the only approved oral drug for treating leishmaniasis caused by intracellular Leishmania parasites that localize in macrophages of the liver, spleen, skin, bone marrow, and lymph nodes.. MTS is extensively distributed in tissues and has prolonged elimination half-lives due to its high plasma protein binding, slow metabolic clearance, and minimal urinary excretion.. Thus, understanding and predicting the tissue distribution of MTS help assess therapeutic and toxicologic outcomes of MTS, especially in special populations, e.g., pediatrics. |
